This podcast is supported by the Icon School of Medicine at Mount Sinai, one of America's leading research medical schools.

Icon Mount Sinai is the academic arm of the eight hospital Mount Sinai health system in New York City.

It's consistently among the top recipients of NIH funding.

Researchers at Icon Mount Sinai have made breakthrough discoveries in many fields vital to

advancing the health of patients, including cancer, COVID and long COVID, cardiology, neuroscience, and

artificial intelligence. The Icon School of Medicine at Mount Sinai, we find a way. Morgan State

University, a Baltimore, Maryland,

Carnegie R2 doctoral research institution, offers more than 100 academic programs and awards

degrees at the baccalaureate, master's, and doctoral levels, is furthering their mission of

growing the future leading the world. Morgan continues to address the needs and challenges of the modern urban environment.

With a four-year quadrupling of research, more than a dozen new doctoral programs,

and eight new national centers of excellence, Morgan is positioned to achieve Carnegie R1

designation in the next five years.

To learn more about Morgan and their

ascension to R1, visit Morgan.edu slash research.

Welcome to the science podcast for August 13, 2021. I'm Sarah Cresby. Each week we feature the most interesting

news and research published in science and the sister journals. First up this week, investigative

journalist Charles Pillar discusses a vitamin D trial that may have put asthmatic children at risk

for broken bones. Next, researcher Baranu Aschete talks with producer Joel Goldberg about the dangers to proprietary

data, government systems, and patient information when the outputs from machine learning are

released on the internet.

Japan's Noster specializes in postbiotic gut microbiota metabolite-based pharmaceuticals research

...